Medical Condition News

RSS

European liver patients’ association launches call to action report for the treatment of heapatic encephalopathy

ELPA today launched a new call to action report ‘Time to DeLiver: Getting a Grip on HE’ at the European Parliament in Brussels. This is the first report from Europe to highlight the significant burden of hepatic encephalopathy on patients, their carers, families and society.

14 Oct 2015

Researchers find significant link between breast cancer and nutrition, explore new preventative treatment

Researchers at Sydney’s Centenary Institute are working on a new treatment aimed at “starving” breast cancer cells, following the discovery of a significant link between breast cancer and nutrition.

14 Oct 2015

Researchers identify new therapeutic target for Duchenne muscular dystrophy

Scientists have found what could one day lead to a promising treatment for those with a crippling disease, Duchenne muscular dystrophy.

14 Oct 2015

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

VolitionRx Limited today announced that full results from a completed clinical study of its NuQ blood-based test for early stage pancreatic cancers have been published in the online issue of Clinical Epigenetics, the official journal of the Clinical Epigenetics Society.

14 Oct 2015

New breakthrough may provide key to understanding how to treat Muscular Dystrophy

New research published today in the journal eLife has demonstrated a new method for observing the behaviour of the protein Dystrophin in a living animal cell, in real-time. This breakthrough may provide a key to understanding how to treat the genetic disease, Muscular Dystrophy.

14 Oct 2015

Antipsychotics initiated frequently and used for long term in Alzheimer's patients

Antipsychotic drugs are initiated in patients with Alzheimer's disease (AD) more frequently than in the general population – already 2–3 years before the Alzheimer's diagnosis, according to a new study from the University of Eastern Finland. Most commonly, antipsychotics were initiated during the six months following the Alzheimer's diagnosis; however, the incidence of new antipsychotic users was high also later on. The results were published in British Journal of Psychiatry.

14 Oct 2015

Lowering systolic blood pressure can reduce risk of left ventricular hypertrophy

Lowering systolic blood pressure below the currently recommended target can reduce the risk of left ventricular hypertrophy (LVH), the most common complication of high blood pressure, according to new research.

14 Oct 2015

Early physical therapy provides only modest benefits for recent-onset low back pain

Early physical therapy for recent-onset low back pain resulted in statistically significant improvement in disability compared to usual care, but the improvement was modest and did not achieve a difference considered clinically important at the individual patient level, according to a study in the October 13 issue of JAMA.

14 Oct 2015

Blocking the production of CHD4 protein may help increase effectiveness of AML treatments

Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness of first-line treatments for acute myeloid leukemia (AML), a particularly lethal blood cancer that is increasing in incidence among older adults.

14 Oct 2015

Sitting for long periods does not increase early death risk, researchers say

New research from the University of Exeter and University College London has challenged claims that sitting for long periods increases the risk of an early death even if you are otherwise physically active.

14 Oct 2015

New tool may help identify high risk atherosclerotic plaques

Researchers have developed and validated a new tool to help identify unstable or high risk atherosclerotic plaques--inflamed fatty deposits in the artery wall and a main contributor to cardiovascular disease (CVD). This breakthrough may lead to better identifying which plaques are considered at the highest risk for rupturing and causing a heart attack or stroke.

14 Oct 2015

ASF launches Autism Sisters Project to accelerate research into 'Female Protective Effect'

The Autism Science Foundation, a not-for-profit organization dedicated to supporting and funding autism research, today announced the launch of the Autism Sisters Project, a new initiative that will give unaffected sisters of individuals with autism the opportunity to take an active role in accelerating research into the "Female Protective Effect."

14 Oct 2015

Bacterium that causes Q fever associated with increased risk of lymphoma

The bacterium that causes Q fever, an infectious disease that humans contract from animals, is associated with an increased risk of lymphoma, according to a study published online today in Blood, the Journal of the American Society of Hematology.

13 Oct 2015

Malaria protein could one day help stop cancer

Scientists at the University of British Columbia, Vancouver Coastal Health and the BC Cancer Agency have discovered a protein from malaria that could one day help stop cancer in its tracks.

13 Oct 2015

Danish researchers face possible breakthrough in fight against cancer

The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim for tests on humans within four years.

13 Oct 2015

UW researchers use noninvasive light-based imaging technology to see inside the living brain

Researchers at the University of Washington have used a noninvasive light-based imaging technology to literally see inside the living brain, providing a new tool to study how diseases like dementia, Alzheimer's, and brain tumors change brain tissue over time.

13 Oct 2015

Sleep apnea associated with evidence of early heart injury in women

Risk factors for obstructive sleep apnea (OSA) and the development of subsequent cardiovascular (CV) complications differ by sex, but it is not clear from prior research whether the effects of sleep apnea on heart disease is similar for men and women.

13 Oct 2015

ViewRay selected as recipient of 2015 Frost & Sullivan Technology Innovation Leadership Award

ViewRay, Inc. announced today that the company has been selected to receive the 2015 Frost & Sullivan Technology Innovation Leadership Award, a prestigious recognition based on an extensive and independent Frost & Sullivan analysis of the North American Image-Guided Radiation Therapy market.

13 Oct 2015

XTL signs agreement with Yeda to amend development milestones for lupus treatment

XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of unmet clinical needs with a focus on treatments for autoimmune diseases, today announced that it has reached agreement with Yeda Research and Development Company Ltd. to amend the development milestones in the License Agreement signed between the parties in January 2014 for the development of hCDR1 for the treatment of systemic lupus erythematosus (SLE).

13 Oct 2015

UCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling tests

GenomOncology today announced that UCLA Health has adopted the GO Clinical Workbench to accelerate analysis and reporting for its tumor DNA profiling tests.

13 Oct 2015

Medical Condition News

European liver patients’ association launches call to action report for the treatment of heapatic encephalopathy

Researchers find significant link between breast cancer and nutrition, explore new preventative treatment

Researchers identify new therapeutic target for Duchenne muscular dystrophy

Clinical study results of VolitionRx's NuQ test for pancreatic cancer published in Clinical Epigenetics

New breakthrough may provide key to understanding how to treat Muscular Dystrophy

Antipsychotics initiated frequently and used for long term in Alzheimer's patients

Lowering systolic blood pressure can reduce risk of left ventricular hypertrophy

Early physical therapy provides only modest benefits for recent-onset low back pain

Blocking the production of CHD4 protein may help increase effectiveness of AML treatments

Sitting for long periods does not increase early death risk, researchers say

New tool may help identify high risk atherosclerotic plaques

ASF launches Autism Sisters Project to accelerate research into 'Female Protective Effect'

Bacterium that causes Q fever associated with increased risk of lymphoma

Malaria protein could one day help stop cancer

Danish researchers face possible breakthrough in fight against cancer

UW researchers use noninvasive light-based imaging technology to see inside the living brain

Sleep apnea associated with evidence of early heart injury in women

ViewRay selected as recipient of 2015 Frost & Sullivan Technology Innovation Leadership Award

XTL signs agreement with Yeda to amend development milestones for lupus treatment

UCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling tests

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News